Generic:
Bevacizumab
Form:
Concentarte for solution for infusion
Strength:
100mg/4ml, 400mg/16ml
Presentation:
Pack of 1’s
Indication:
It is used to treat Metastatic colorectal cancer, Non-squamous , Non–small cell lung cancer, Recurrent glioblastoma, Metastatic renal cell carcinoma, Persistent, Recurrent or metastatic cervical cancer, Epithelial ovarian, Fallopian tube, or primary peritoneal cancer and hepatocellular carcinoma.